◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY
Daicel Corporation (4202)
来自官方财务报表的收入、利润与现金流历史。
Basic Materials · 华尔街（美国） · 最近更新： 2026-10-02
Daicel Corporation engages in the materials, medical/healthcare, smart, safety, and engineering plastics businesses in Japan and internationally. The company offers medical/healthcare products, including BELLOCEA S7, a spherical cellulose acetate particle; FLAVOCELL S-Equol; Urolithin A; polyglycerols; konjac ceramide; excipients for foods; chiral columns and reagents; and Actranza lab, as well as separation and analytical services.
关键数据
- 市值: JPY 359 billion
- 收入（截至 2026-03-31 财年）: JPY 579.6B
- 净利润: JPY 10.2B
- 毛利率: 25.2%
- 净利率: 1.8%
查看交互式图表与完整报表 →
估值模型 (DCF) →
年度利润表
| 利润表 | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|
| 总收入 | JPY 579.6B | JPY 586.5B | JPY 558.1B | JPY 538.0B |
| 毛利 | JPY 146.3B | JPY 164.7B | JPY 159.3B | JPY 145.8B |
| 营业利润（EBIT） | JPY 42.1B | JPY 61.0B | JPY 62.4B | JPY 47.5B |
| 净利 | JPY 10.2B | JPY 49.5B | JPY 55.8B | JPY 40.7B |
来源：公司公开报告（SEC）。在依赖任何数字前请核对 SEC EDGAR。
资产负债表、现金流、季度数据与完整财务比率见 4202 交互式查看器。 /companies/us/4202
类似公司
本网站信息仅用于教育与参考，不构成投资建议。不发布目标价或买卖建议。
About TickerBase · Data methodology & sources · Privacy · Terms
TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.